IPC devices market seen reaching $2.29 billion by 2030

The Business Research Company says the intermittent pneumatic compression devices market will grow from $1.7 billion in 2026 to $2.29 billion by 2030, a 7.8% CAGR. Rising spinal cord injury cases, more home-based care and connected compression systems are driving demand.

Why it matters: - Intermittent pneumatic compression devices help prevent deep vein thrombosis and support circulation in patients with vascular and mobility challenges. - The market’s projected rise signals growing demand for preventive therapy in hospitals, outpatient settings and at home. - The expansion also points to a broader shift toward connected and portable care tools that can be used beyond traditional clinical settings.

What happened: - The Business Research Company released a 2026 report on the global intermittent pneumatic compression devices market. - The market is projected to increase from $1.57 billion in 2025 to $1.7 billion in 2026. - The report forecasts the market will reach $2.29 billion by 2030. - The forecast implies a 7.9% CAGR from 2025 to 2026 and a 7.8% CAGR through 2030. - North America held the largest share of the global market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - IPC devices use inflatable cuffs that wrap around the limbs and apply controlled pressure in cycles of inflation and deflation. - The devices aid blood flow by compressing and releasing specific areas. - IPC therapy helps prevent blood clots such as deep vein thrombosis. - The devices are also used to manage lymphedema and support patients with vascular and circulatory challenges. - The report links past growth to rising cases of deep vein thrombosis, broader use of preventive compression therapies, better device design and wider clinical recognition of IPC benefits. - Future growth drivers include home-based thrombosis prevention, connected compression systems, outpatient care models, preventive vascular health and ongoing compression therapy innovation. - The report says rising spinal cord injury cases are a major driver of demand. - Spinal cord injuries can cause loss of motor and sensory function below the injury site and may lead to paralysis. - In May 2023, the Spinal Cord Injury Statistical Center reported about 18,000 new spinal cord injury cases in the United States, up from an estimated 17,900 in 2022. - IPC devices can help manage these patients by preventing DVT through sequential limb compression.

Between the lines: - The market outlook reflects a healthcare model that is moving from reactive treatment toward prevention and monitoring. - Portable and connected IPC systems could widen adoption by making therapy easier to use outside hospitals. - Home care and outpatient growth may favor devices that improve compliance and lower the burden on clinical staff. - The spinal cord injury trend adds a durable clinical use case because these patients often need ongoing clot prevention.

What's next: - Market growth will likely hinge on how quickly providers adopt connected and portable compression systems. - Wider use in home-based and outpatient care could expand the addressable market beyond hospital procurement. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis. - The Business Research Company is positioning the report as a broader strategic planning tool for market participants.

The bottom line: - IPC devices are moving from a niche hospital tool to a broader preventive care category, with demand supported by chronic patient needs and technology that makes treatment more flexible.